Role of non-ionic surfactant on the interaction of drugs with bovine serum albumin (BSA)
Source abstract
Abstract
Serum albumins are the soluble protein part in the circulatory system. They have a significant role in transport and delivery of drug in blood. Bovine serum albumin (BSA) is generally used as model protein which is structurally similar to human serum albumin. Interaction of drug at the protein binding level can induce many changes like distribution rate, elimination of drug or most importantly solubilisation of a hydrophobic drug. Protein–surfactant interaction employed to cause conformational changes in protein by change of polarity and on many occasions help in stabilisation of protein. Generally, non-ionic surfactants are used for these purposes and hence are widely studied. The studies on drug binding with BSA in presence of non-ionic surfactant are, however, rare in literature. In this study, four drugs are taken for analysing their binding with BSA in presence of a non-ionic, hydrophobic surfactant, pluronic L-81, and investigate their role in the system. The drugs are tinidazole, piroxicam, methylparaben and propylparaben. The characterisations were done using UV–visible spectroscopy and fluorescence spectroscopy. The UV spectroscopic measurements were conducted for BSA–drug mixtures without and with pluronic L-81. The absorbance values were used for determining the binding constant values using Benesi–Hildebrand (B-H) plot. Fluorimetry studies of the BSA + L-81 + drug mixtures were carried out at room temperature which showed that there was quenching effect on addition of drug to BSA + L-81 mixture. Furthermore, the quenching was of dynamic nature. The fluorescence data were analysed using Stern–Volmer and Lineweaver–Burk equations. With the data, association constant KA for all the systems were determined. The docking studies confirmed the binding of the drugs with BSA.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Protein Interaction Studies and Fluorescence Analysis · Protein purification and stability · Surfactants and Colloidal Systems
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
A.V.C. College (Autonomous) Department of Chemistry, , Mayiladuthurai,
P.S.R. Engineering college (Autonomous) Department of Chemistry, , Sivakasi,
References (54)
Show source-provided references
1. Spectral characterization of the binding and conformational changes of bovine serum albumin upon interaction with an anti-fungal drug, methylparaben10.1016/j.saa.2012.12.055 ↗
2. Atomic structure and chemistry of human serum albumin10.1038/358209a0 ↗
3. Investigation of the interaction between ofloxacin and bovine serum albumin: Spectroscopic approach10.1007/s10953-010-9527-8 ↗
4. Conformational transitions of the three recombinant domains of human serum albumin depending on pH10.1074/jbc.275.5.3042 ↗
5. Determination of LMF binding site on a HSA-PPIX complex in the presence of human holo transferrin from the viewpoint of drug loading on proteins10.1371/journal.pone.0084045 ↗
6. A comparison study of the interaction between β-lactoglobulin and retinol at two different conditions: spectroscopic and molecular modeling approaches10.1080/07391102.2014.977351 ↗
7. Lomefloxacin promotes the interaction between human serum albumin and transferrin: a mechanistic insight into the emergence of antibiotic’s side effects10.1016/j.jpba.2010.12.029 ↗
8. Mechanism for stabilization of the molten globule state of papain by sodium n-alkyl sulfates: Spectroscopic and calorimetric approaches10.1016/j.jcis.2008.03.001 ↗
9. ZnO-ZnS QDs interfacial heterostructure for drug and food delivery application: enhancement of the binding affinities of flavonoid aglycones to bovine serum albumin10.1016/j.nano.2011.02.003 ↗
10. Study on effect of lomefloxacin on human holo-transferrin in the presence of essential and nonessential amino acids: Spectroscopic and molecular modeling approaches10.1016/j.ijbiomac.2017.01.047 ↗
11. Caveolin1 tyrosine-14 phosphorylation: role in cellular responsiveness to mechanical cues10.1007/s00232-020-00143-0 ↗
12. Amphipol-mediated screening of molecular orthoses specific for membrane protein targets10.1007/s00232-014-9707-3 ↗
13. Thermodynamic studies on the interaction of n-alkyl sulfates with insulin in- aqueous solution10.1039/ft9928801003 ↗
14. Biosurfactants and surfactants interacting with membranes and proteins: same but different10.1016/j.bbamem.2016.09.024.s ↗
15. Evolution of interactions in the protein solution as induced by mono and multivalent ions10.1021/acs.biomac.9b00374 ↗
16. Spectroscopic studies on the interaction of cationic surfactants with bovine serum albumin10.1016/j.colsurfb.2008.11.009 ↗
17. Interaction of bovine serum albumin with gemini surfactants10.1016/j.jcis.2010.03.017 ↗
18. Studies on bovine serum albumin-sodium dodecyl sulfate complexes using pyrene fluorescence probe and 5-doxylstearic acid spin probe10.1016/j.jcis.2004.06.023 ↗
19. A systematic study of bovine serum albumin (BSA) and sodium dodecyl sulfate (SDS) interactions by surface tension and small angle X-ray scattering10.1016/S0021-9797(03)00109-7 ↗
20. Effect of bovine serum albumin on the surface properties of ionic liquid-type gemini surfactant10.1080/01932691.2017.1417132 ↗
21. Facile synthesis of impurity-free iron single atom catalysts for highly efficient oxygen reduction reaction and active-site identification10.1039/c9cy01512d ↗
22. Interaction of repaglinide with bovine serum albumin: Spectroscopic and molecular docking approaches10.1016/j.jpha.2019.03.007 ↗
23. Interaction of ibuprofen with partially unfolded bovine serum albumin in the presence of ionic micelles and oligosaccharides at different λex and pH: a spectroscopic analysis10.1021/acsomega.2c06447 ↗
24. Study of interactions of an anticancer drug neratinib with bovine serum albumin: spectroscopic and molecular docking approach10.3389/fchem.2018.00047 ↗
25. Investigation of aggregation behavior of ibuprofen sodium drug under the influence of gelatin protein and salt10.1016/j.molliq.2019.111187 ↗
26. Effect of additives (TX-114) on micellization and microstructural phenomena of amphiphilic ibuprofen drug (sodium salt): multi-technique approach10.1016/j.jlumin.2018.01.042 ↗
27. Conformational study of spectrin in presence of submolar concentrations of denaturants10.1007/s10895-005-0214-x ↗
28. Spatial localization of ligand binding sites from electron current density surfaces calculated from NMR chemical shift perturbations10.1021/ja026166c ↗
29. Developments in small-angle X-ray scattering (SAXS) for characterizing the structure of surfactant-macromolecule interactions and their complex10.1016/j.ijbiomac.2023.126288 ↗
30. Mixed micelle formation with hydrophobic and hydrophilic pluronic block copolymers: implications for controlled and targeted drug delivery10.1016/j.colsurfb.2011.08.002 ↗
31. Interactions of bovine serum albumin with ionic surfactants in aqueous solutions10.1016/S0268-005X(02)00040-1 ↗
32. Comparison of the conformational stability of the non-native α-helical intermediate of thiol-modified β-lactoglobulin upon interaction with sodium n-alkyl sulfates at two different pH10.1016/j.jcis.2006.02.049 ↗
33. The effect of protein-surfactant interaction on magnesite rock flotation
34. A novel method for determination of tinidazole and metronidazole in aqueous solutions based on fluorescence quenching of functionalized CdS quantum dots as luminescent probes10.1016/j.fjps.2018.03.003 ↗
35. Classification framework and chemical biology of tetracycline-structure-based drugs10.3390/antibiotics1010001 ↗
36. Simultaneous estimation of ofloxacin and ornidazole in solid dosage form by U V
37. Two stability-indicating UV spectrophotometric methods for the analysis of hydrolyzed tinidazole10.1016/S0731-7085(02)00667-2 ↗
38. Spectroscopic analysis on the binding interaction of biologically active pyrimidine derivative with bovine serum albumin10.1016/j.jpha.2015.07.001 ↗
39. Study of interaction of silver nanoparticles with bovine serum albumin using fluorescence spectroscopy10.1007/s10895-011-0922-3 ↗
40. Preparation and characterization of novel anti-inflammatory biological agents based on piroxicam-loaded poly-ε-caprolactone nano-particles for sustained NSAID delivery10.1080/10717544.2020.1716881 ↗
41. Determination of methyl paraben from cosmetics by UV spectroscopy
42. Spectrophotometric method for the microdetermination of methyl and propyl paraben in some detergents through charge transfer complex10.22317/iqnjc.06201706 ↗
43. Simultaneous determination of isothiazolinones and parabens in cosmetic products using solid-phase extraction and ultra-high performance liquid chromatography/diode array detector10.3390/ph13110412 ↗
44. Analysis of aceclofenac and bovine serum albumin interaction using fluorescence quenching method for predictive, preventive, and personalized medicine10.1186/s13167-015-0047-x ↗
45. Fast and ultrafast spectroscopic investigation of tetracycline derivatives in organic and aqueous media10.1039/c0cp00044b ↗
46. Analysis of binding interaction between bovine serum albumin and the cobalt(II) complex with salicylaldehyde-2-phenylquinoline-4-carboylhydrazone10.1248/cpb.57.1237 ↗
47. Investigation of the interaction between mechanosynthesized ZnS nanoparticles and albumin using fluorescence spectroscopy10.3390/ph16091219 ↗
48. Cytotoxicity induced by tetracyclines via protein photooxidation10.1155/2015/787129 ↗
49. Green synthesized silver and copper nanoparticles using solanum trilobatum root extract and comparative study of characterization10.1134/S1070428024070182 ↗
50. Interaction between olanzapine and human serum albumin and effect of metal ions, caffeine and flavonoids on the binding: a spectroscopic study10.1016/j.saa.2020.119295 ↗
51. Unravelling the interaction mechanism between clioquinol and bovine serum albumin by multi-spectroscopic and molecular docking approaches10.1016/j.saa.2019.03.004 ↗
52. Glycoconjugates based on supramolecular tröger’s base scaffold: synthesis, photophysics, docking, and BSA association study10.1021/acsomega.9b01857 ↗
53. Cytotoxic behavior and DNA/BSA binding activity of thiosemicarbazone based Ni(II) complex: bio-physical, molecular docking and DFT study10.1016/j.molliq.2023.121921 ↗
54. Crystal design, antitumor activity and molecular docking of novel palladium(II) and gold(III) complexes with a thiosemicarbazone ligand10.3390/ijms241411442 ↗